Malcolm Hoffman
Stock Analyst at BMO Capital
(0.65)
# 4,229
Out of 5,078 analysts
10
Total ratings
25%
Success rate
-13.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Malcolm Hoffman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $34 | $19.73 | +72.33% | 6 | Oct 12, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $310 | $145.04 | +113.73% | 3 | Sep 14, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $46 | $38.73 | +18.77% | 1 | Jul 21, 2026 |
Acadia Pharmaceuticals
Oct 12, 2026
Reiterated: Buy
Price Target: $34
Current: $19.73
Upside: +72.33%
Axsome Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: $310
Current: $145.04
Upside: +113.73%
LB Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $38.73
Upside: +18.77%